Back to Search
Start Over
Saturated fatty acids activate caspase-4/5 in human monocytes, triggering IL-1β and IL-18 release.
- Source :
-
American journal of physiology. Endocrinology and metabolism [Am J Physiol Endocrinol Metab] 2016 Nov 01; Vol. 311 (5), pp. E825-E835. Date of Electronic Publication: 2016 Sep 13. - Publication Year :
- 2016
-
Abstract
- Obesity is associated with metabolic tissue infiltration by monocyte-derived macrophages. Saturated fatty acids contribute to proinflammatory gene induction in tissue-embedded immune cells. However, it is unknown how circulating monocytes, the macrophage precursors, react to high-fat environments. In macrophages, saturated fatty acids activate inflammatory pathways and, notably, prime caspase-associated inflammasomes. Inflammasome-activated IL-1β contributes to type 2 diabetes. We hypothesized that 1) human monocytes from obese patients show caspase activation, and 2) fatty acids trigger this response and consequent release of IL-1β/IL-18. Human peripheral blood monocytes were sorted by flow cytometry, and caspase activity was measured with a FLICA dye-based assay. Blood monocytes from obese individuals exhibited elevated caspase activity. To explore the nature and consequence of this activity, human THP1 monocytes were exposed to saturated or unsaturated fatty acids. Caspase activity was revealed by isoform-specific cleavage and enzymatic activity; cytokine expression/release was measured by qPCR and ELISA. Palmitate, but not palmitoleate, increased caspase activity in parallel to the release of IL-1β and IL-18. Palmitate induced eventual monocyte cell death with features of pyroptosis (an inflammation-linked cell death program involving caspase-4/5), scored through LDH release, vital dye influx, cell volume changes, and nuclear morphology. Notably, selective gene silencing or inhibition of caspase-4/5 reduced palmitate-induced release of IL-1β and IL-18. In summary, monocytes from obese individuals present elevated caspase activity. Mechanistically, palmitate activates a pyroptotic program in monocytes through caspase-4/5, causing inflammatory cytokine release, additional to inflammasomes. These caspases represent potential, novel, therapeutic targets to taper obesity-associated inflammation.<br /> (Copyright © 2016 the American Physiological Society.)
- Subjects :
- Adult
Caspase Inhibitors pharmacology
Caspases genetics
Caspases metabolism
Caspases, Initiator genetics
Caspases, Initiator metabolism
Cell Line
Diabetes Mellitus, Type 2 complications
Enzyme-Linked Immunosorbent Assay
Fatty Acids, Monounsaturated pharmacology
Female
Flow Cytometry
Fluorescent Antibody Technique
Gene Silencing
Humans
Immunoblotting
Interleukin-18 metabolism
Interleukin-1beta metabolism
Male
Middle Aged
Monocytes metabolism
Overweight complications
Palmitates pharmacology
Pilot Projects
Polymerase Chain Reaction
Pyroptosis drug effects
RNA, Messenger metabolism
Caspases drug effects
Caspases, Initiator drug effects
Diabetes Mellitus, Type 2 metabolism
Fatty Acids pharmacology
Interleukin-1beta drug effects
Monocytes drug effects
Obesity metabolism
Overweight metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1522-1555
- Volume :
- 311
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- American journal of physiology. Endocrinology and metabolism
- Publication Type :
- Academic Journal
- Accession number :
- 27624102
- Full Text :
- https://doi.org/10.1152/ajpendo.00296.2016